5Torres A, Ewing S, Insausti J, et al. Etiology and microbial patterns of pulmonary infiitrates in patients with orthotopic livertransplantation. Chest ,2000,117:494 - 502.
6Monso E, Ruiz J, Rosell A, et al. Bacterial infection in chronic obstructive pulmonary disease;A stable and exacerbated outpatients using the protected specimen brash. Am J Respir Crit Care Med, 1995,152 : 1316.
7Sirvent JM, Vidaur L, Gonzalez S, et al. Microscopic examination of intracellular organisms in protected bronchoalveolar minilavage fluid for the diagnosis of ventilator - associated pneumonia. Chest, 2003, 123:518 - 526.
8Force ville X, Fiaere A, Faibi S F, et al. Reproducibility of protected specimen brush and bronehoalveloar lavage conserved at 4 degrees C for 48 hours. Intensive Care Med ,2002,28:857 - 863.
9Wosks HJ, Roding T, Schulz I, et al. Ventilator-associated pneumonia in surgical intensive care unit: epidemiology, etiology and comparison of three bronchoscopic me thods for microbiological specimen sampling. Crit Cam,2001,5 : 167 - 173.
6Ai W, Yue Y, Xiong S, et al. Enhanced protection against pulmonary mycobacterial challenge by chitosan-formulated polyepitope gene vaccine is associated with increased pulmonary secretory IgA and gamma-interferon(+) T cell responses. Microbiology Immunology, 2013, 57(3):224-235.
